Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2020-03-26 | 2020-07-10 | 109638 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-09-24 | 2020-11-26 | 124968 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-22 | 2020-12-17 | 126912 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-22 | 2021-04-21 | 126942 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-03-25 | 2021-05-13 | 136317 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-03-25 | 2021-04-29 | 136332 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-09-02 | 2022-01-20 | 145124 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-09-30 | 2022-01-20 | 146446 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2022-01-27 | 2022-11-12 | 153733 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2022-04-21 | 2022-11-12 | 159198 |
TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2022-06-09 | 2023-06-09 | 162257 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176812 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-04-27 | 2023-07-05 | 190752 |
TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2023-06-08 | 2023-11-03 | 194135 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-06-19 | 2023-10-06 | 195566 |
TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195588 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-06-20 | 2023-10-06 | 195803 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-06-20 | 2023-10-06 | 195824 |
TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2024-01-25 | 2024-04-01 | 217234 |
TEVA-TELMISARTAN HCTZ | 80.0MG 25.0MG | TABLET | Resolved | 2020-04-03 | 2020-05-14 | 110788 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |